Prakiraan rega marang bathi: Alcon (ALC)

ALC (Alcon Vision) - tandha merek perusahaan

Alcon Inc. (ALC) leadership in ophthalmic surgery and its patent portfolio are confirmed by the change in the company's expected P/E ratio on the GURU.Markets basic chart, where the current value is 19.20. Stable demand for medical devices eliminates the impact of seasonality and market cycles. High switching costs for clinics transitioning to other systems further strengthen the issuer's market position.

ALC - Rasio prakiraan rega marang bathi Alcon ing rentang 04.07.2022 - 10.11.2026

Rincian analitis perusahaan Alcon Inc.

- kuotasi lan prakiraan analis:
Rega saham Alcon|ALC - Rata-rata rega prakiraan
- indikator kapitalisasi bursa perusahaan:
Biji pasar Alcon Inc|ALC - Total Nilai Perusahaan
- statistik nilai buku emiten:
Nilai Buku saben Saham Alcon|ALC - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku alcon.com|ALC - Gunggung Aset Perusahaan
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Alcon Inc.|ALC - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Alcon Inc.|ALC - Utang perusahaan|Utang-utang marang kapitalisasi buku Alcon Inc|ALC - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Alcon|Likuiditas cepet alcon.com
- statistik bathi lan rasio pasar:
ALC - Bathi perusahaan|Bathi mangsa ngarep Alcon Inc.|ALC - Nilai perusahaan marang bathi resik|Pangali Forward P/E Alcon Vision|ALC - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Alcon Inc|ALC - Bathi operasional sadurunge amortisasi|Bathi resik saben saham (EPS TTM) Alcon|ALC - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan alcon.com|ALC - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Alcon Inc.
Analisis umum perusahaan:Alcon
Produk merek Alcon Inc.

Forward P/E relates current market capitalization to expected earnings, determining the degree of an asset's overvaluation. For Alcon Inc. (ALC), this calculation reflects market confidence in the monetization of large-scale R&D investments and ophthalmological innovations. By analyzing the projected P/E multiple of Alcon Inc. (ALC), an investor can observe future return dynamics against the backdrop of the business's scientific stability. Sharp deviations in this indicator signal either risks or hidden growth potential. The fundamental resilience of this industry leader is confirmed by the balance between valuation and real technological achievements.

Pesaing Alcon Inc.

Pangali Forward P/E BLCO|GKOS - Rasio prakiraan rega marang bathi|Apellis Pharmaceuticals Inc - Prakiraan rega marang bathi|Belite Bio (BLTE) - Rasio prakiraan rega marang bathi|Ocular Therapeutix - Pangali Forward P/E|Rasio prakiraan rega marang bathi harrowinc.com|Viridian Therapeutics, Inc. (VRDN) - Rega marang bathi mangsa ngarep|LENZ - Kapitalisasi marang proyeksi bathi|OCS (Oaktree Specialty Lending) - Pangali Forward P/E|Pangali Forward P/E EyePoint Corp|Rega marang bathi mangsa ngarep Kodiak Sciences Inc. (KOD)|Rega marang bathi mangsa ngarep ALDX (aldeyra.com)|Pangali Forward P/E KALA (KALA BIO)|IRD - Prakiraan rega marang bathi|OKYO - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Adverum Biotechnologies|Outlook Therapeutics (OTLK) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep CLSD|Prakiraan rega marang bathi NBY|KPRX: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ALIM|Kapitalisasi marang proyeksi bathi eyenovia.com|Rega marang bathi mangsa ngarep Guardion Health Science GHSI|OCUP: Rasio rega marang bathi mangsa ngarep|Opthea - Pangali Forward P/E